We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 234

Pharma in brief - Canada: Merck awarded substantial damages for infringement of lovastatin patent
  • Norton Rose Fulbright LLP
  • Canada
  • July 31 2013

The Federal Court held that Merck and Co., Inc. (“Merck US”) and Merck Canada Inc. (“Merck Canada”) (collectively “Merck”) are entitled to $119,054

A roadmap for IP protection strategies for oil and gas technologies
  • Norton Rose Fulbright LLP
  • Canada
  • November 26 2013

Owing to the depletion of existing resources and geopolitical factors, participants in the energy marketplace are searching for alternatives to crude

Avoiding intellectual property pitfalls in the oil and gas industry
  • Norton Rose Fulbright Canada LLP
  • Canada
  • June 3 2013

Whether it involves conventional or unconventional resources, participants in the oil and gas value chain are innovating to overcome technological

Doing business in Canada - December 2014
  • Norton Rose Fulbright LLP
  • Canada
  • December 2 2014

Canada is a member of a wide network of international treaties that offer protection of investments in Canada to foreign investors from countries

IP due diligence: beyond the usual suspects
  • Norton Rose Fulbright LLP
  • Canada, USA
  • December 4 2014

Conducting a due diligence review of intellectual property (IP) matters as part of a merger or acquisition has become commonplace with the growing

Combatting counterfeiting
  • Norton Rose Fulbright LLP
  • Canada
  • December 15 2014

Bill C-8, the Combatting Counterfeit Products Act received Royal Assent on December 9, 2014. All of the provisions criminalizing possession for sale

The folly of a press release
  • Norton Rose Fulbright Australia
  • Australia
  • September 26 2014

Madden had falsely accused Seafolly of copying her designs. However, an unresolved part of that dispute concerned a series of misleading social media

The hazards of intellectual property issues in employment agreements
  • Norton Rose Fulbright LLP
  • Global
  • October 2 2014

Businesses of all sizes are increasingly becoming aware of the strategic and commercial value of intellectual property (IP). Startups which are just

UK Intellectual Property Office (IPO) cracks down on misleading invoices
  • Norton Rose Fulbright LLP
  • United Kingdom
  • September 19 2014

The UK Intellectual Property Offices warns trade mark owners to not be fooled by "'renewal' notices to holders of UK registered patents and trade

The value of intellectual property: innovating remote signing of legal documents
  • Norton Rose Fulbright LLP
  • USA
  • June 25 2014

Margaret Atwood speaks about IP, innovation, and demonstrates the electronic signature solution of Norton Rose Fulbright client Syngrafii at our